Professor, chair of the Department of Epidemiology, and Joseph S. Copes Chair of Epidemiology Jian He is a nationally and internationally known expert in the clinical, translational, and epidemiological research of cardiovascular and kidney diseases. He has conducted novel studies in obesity, hypertension, diabetes, stroke, cardiovascular disease, and chronic kidney disease funded by the National Institutes of Health. He has been the principal investigator and co-investigator for more than 30 major research awards from the National Institutes of Health worth more than 150 million U.S. dollars. Dr. He has authored over 400 scientific articles and has published in first class biomedical journals, including New England Journal of Medicine, Journal of The American Medical Association, Lancet, and National Genetics. He has received many awards from local, national, and international academic institutions and professional societies. He directs the Tulane University Translational Science Institute which promotes high-impact clinical, translational, and implementation research at Tulane University.
Areas of Expertise (11)
Cardiovascular Disease Prevention
Global Cardiovascular Disease Epidemiology
Clinical Trials and Implementation Sciences
Highly Cited Researchers (Clinical Medicine)
Oliver Fund Award for Excellence in Faculty Mentoring
President's Award for Excellence in Research
Peking Union Medical College and Chinese Academy of Medical Sciences
Distinguished Alumnus Award
Johns Hopkins University
The Johns Hopkins University: Ph.D., Clinical Epidemiology
Jianxi Medical College: B.A., Clinical Medicine
Peking Union Medical College and Chinese Academy of Medical Sciences: M.D., Cardiovascular Disease Epidemiology
Tulane University: M.S.
- American College of Epidemiology
- American Heart Association
Media Appearances (5)
Substance Use Ups Risks for CKD Progression, Mortality
Renal & Urology News online
In a multivariable adjusted model, persistent tobacco smoking was associated with a significant 1.9-fold increased risk of death compared with nonsmoking, Jiang He, MD, PhD, of Tulane University School of Public Health and Tropical Medicine, and colleagues reported. Persistent use of hard illicit drugs was associated with a significant 1.25- and 1.41-fold increased risk of CKD progression and death, respectively, compared with nonuse. Cocaine use was associated with a significant 2-fold increased risk of death. Heroin use was associated with a significant 1.6-fold increased risk of CKD progression...
Keeping people within U.S. blood pressure guidelines saves lives
Science News online
But adhering to the guidelines means doctors may recommend that 83 million adults, 11 million more than before, take blood pressure medications. Those drugs carry a risk of side effects, including kidney damage or abnormally low blood pressure. Of those taking the drugs, 62,000 people’s blood pressure could dip too low and 79,000 might suffer kidney injury or failure, epidemiologist Jiang He of Tulane University in New Orleans and his colleagues estimate...
Controversial 2017 hypertension guidelines could save 300K lives every year
Cardiovascular Business online
The researchers, led by first author Jiang He, MD, PhD, of Tulane University School of Public Health and Tropical Medicine in New Orleans sought to estimate the effects of both the 2017 and 2014 hypertension guidelines on proportions of adults defines as having high blood pressure or recommended for antihypertensive treatment and reductions in cardiovascular disease and mortality...
Coronary Artery Calcification Risk Factors in CKD Identified
Renal & Urology News online
To understand why CAC is more common and severe in CKD patients, Jiang He, MD, PhD, of Tulane University School of Public Health and Tropical Medicine in New Orleans, and colleagues assessed CAC progression by computed tomography and Agatston measurements in 1123 racially and ethnically diverse patients (aged 21–74 years) with stage 2 to 4 CKD from the Chronic Renal Insufficiency Cohort (CRIC) study.
BP Control Best Achieved With Multipronged Approach
The current analysis clearly demonstrates that "multicomponent strategies at health system, provider, and patient levels are essential for blood pressure control in patients with hypertension," Dr Jiang He (Tulane University, New Orleans, LA) told theheart.org | Medscape Cardiology...
Noncommunicable chronic diseases have become the leading causes of mortality and disease burden worldwide.
Because of the rapid change in lifestyle in China, there is concern that diabetes may become epidemic. We conducted a national study from June 2007 through May 2008 to estimate the prevalence of diabetes among Chinese adults.
With China's rapid economic development, the disease burden may have changed in the country. We studied the major causes of death and modifiable risk factors in a nationally representative cohort of 169,871 men and women 40 years of age and older in China.
Reliable information about the prevalence of hypertension in different world regions is essential to the development of national and international health policies for prevention and control of this condition. We aimed to pool data from different regions of the world to estimate the overall prevalence and absolute burden of hypertension in 2000, and to estimate the global burden in 2025.
Physical activity has been associated with reduced blood pressure in observational epidemiologic studies and individual clinical trials. This meta-analysis of randomized, controlled trials was conducted to determine the effect of aerobic exercise on blood pressure.